| Literature DB >> 32549390 |
Faten Bashar Kamal Eddin1, Yap Wing Fen1,2.
Abstract
For a healthy life, the human biological system should work in order. Scheduled lifestyle and lack of nutrients usually lead to fluctuations in the biological entities levels such as neurotransmitters (NTs), proteins, and hormones, which in turns put the human health in risk. Dopamine (DA) is an extremely important catecholamine NT distributed in the central nervous system. Its level in the body controls the function of human metabolism, central nervous, renal, hormonal, and cardiovascular systems. It is closely related to the major domains of human cognition, feeling, and human desires, as well as learning. Several neurological disorders such as schizophrenia and Parkinson's disease are related to the extreme abnormalities in DA levels. Therefore, the development of an accurate, effective, and highly sensitive method for rapid determination of DA concentrations is desired. Up to now, different methods have been reported for DA detection such as electrochemical strategies, high-performance liquid chromatography, colorimetry, and capillary electrophoresis mass spectrometry. However, most of them have some limitations. Surface plasmon resonance (SPR) spectroscopy was widely used in biosensing. However, its use to detect NTs is still growing and has fascinated impressive attention of the scientific community. The focus in this concise review paper will be on the principle of SPR sensors and its operation mechanism, the factors that affect the sensor performance. The efficiency of SPR biosensors to detect several clinically related analytes will be mentioned. DA functions in the human body will be explained. Additionally, this review will cover the incorporation of nanomaterials into SPR biosensors and its potential for DA sensing with mention to its advantages and disadvantages.Entities:
Keywords: biosensors; diagnosis; dopamine; nanomaterials; neurotransmitters; optical; surface plasmon resonance
Year: 2020 PMID: 32549390 PMCID: PMC7356898 DOI: 10.3390/molecules25122769
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Experimental set-up of surface plasmons (SPs) excitation.
Figure 2(a) A dip in the intensity of the reflected light after SPs excitation and (b) an angular shift from a to b due to a refractive index (RI) change on the Au film.
Figure 3Direct label free detection.
Figure 4Surface plasmon resonance (SPR) sensogram.
Figure 5Neuron communication process.
SPR sensors for dopamine (DA) detection.
| Material | LOD | Detection Range | References |
|---|---|---|---|
| MIP-Au electrode | 1 pM | - | [ |
| DA-RC | 0.085 ng/mL | 0.085 ng/mL–700 ng/mL | [ |
| DA antibodies/Au NPs/ITO | 1 nM | 0.001–100 µM | [ |
| Ag@GO | 30 nM | 100 nM–2 µM | [ |
| Ag NPs | 0.2 µM | 0.2–30 µM | [ |
| Conjugated polymer P(NIPAAm149-st-MAAmBO19) and P(LAEMA21) | 1 nM | 1 nM–0.1 mM | [ |
| Pt | 50 pM | 0.1 nM–32 µM | [ |
| DAAPT-AuNPs | 200 fM | 100 µM–2 mM | [ |
| Molecular Imprinted GNP/SnO2 Nanocomposite | 31 nM | 0–100 µM | [ |
| Au/graphene/DBA D-POF | - | 0.1 nM–1 µM | [ |
Comparison of the detection limits of various DA sensors.
| Method | Lowest Detection Limit | References |
|---|---|---|
| EC | 78 fM | [ |
| CL | 0.19 nM | [ |
| ECL | 0.31 pM | [ |
| Fluorescence | 0.1 pM | [ |
| Spectrophotometry | 0.4 nM | [ |
| Colorimetry | 0.16 nM | [ |
| SERS | 0.006 pM | [ |
| RRS | 0.392 ng/mL | [ |
| PRRS | 0.1 pM | [ |
| SPS | 1.7 µM | [ |
| PL | 10 nM | [ |
| Absorption | 1.2 nM | [ |
| PEC | 2.3 pM | [ |
| SPR | 200 fM | [ |
E—Electrochemical; CL—Chemiluminescence; ECL—Electrochemiluminescence; SERS—Surface-enhanced Raman spectroscopy; RRS—Resonance Rayleigh scattering; PRRS—Plasmonic resonance Rayleigh scattering; SPS—Solid phase spectrophotometry; PL—Photoluminescence; PEC—Photoelectrochemical; SPR—Surface plasmon resonance.